BioGaia Probiotic Cuts Infant Distress Time 43% After Seven Days in Trial

By Public Technologies
  • BioGaia announced November 3, 2026, that a published clinical trial found Protectis Plus BABY reduced infant colic compared with placebo.
  • Results appeared in Nutrients on October 22, 2026; the 21-day randomized, double-blind trial enrolled 50 infants, with 48 included in analyses.
  • Infant distress declined significantly within seven days, including reduced inconsolable crying; improvements continued throughout the study.
  • The dual-strain probiotic drops were well tolerated.
  • Protectis Plus BABY has launched in four European markets, with expansion into additional markets planned soon.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. BioGaia AB published the original content used to generate this news brief on November 03, 2026, and is solely responsible for the information contained therein.

Capital.com is an execution-only brokerage platform and the content provided on the Capital.com website is intended for informational purposes only and should not be regarded as an offer to sell or a solicitation of an offer to buy the products or securities to which it applies. No representation or warranty is given as to the accuracy or completeness of the information provided.
The information provided does not constitute investment advice nor take into account the individual financial circumstances or objectives of any investor. Any information that may be provided relating to past performance is not a reliable indicator of future results or performance.
To the extent permitted by law, in no event shall Capital.com (or any affiliate or employee) have any liability for any loss arising from the use of the information provided. Any person acting on the information does so entirely at their own risk.